Filing Details
- Accession Number:
- 0001140361-18-024271
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-16 17:15:14
- Reporting Period:
- 2018-05-14
- Accepted Time:
- 2018-05-16 17:15:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | LIFE | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1598292 | Ecor1 Capital Fund Qualified, L.p. | 409 Illinois Street San Francisco CA 94158 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-14 | 354,791 | $1.72 | 2,854,525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-15 | 121,294 | $1.43 | 2,733,231 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-16 | 2,733,231 | $0.81 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
